Impact of Previous Cardiac Surgery on Outcomes After Tricuspid Valve Transcatheter Edge-to-Edge Repair: Insights from EuroTR - Scorecard - MDSpire

Impact of Previous Cardiac Surgery on Outcomes After Tricuspid Valve Transcatheter Edge-to-Edge Repair: Insights from EuroTR

  • By

  • Dario Grassini

  • Karl-Patrik Kresoja

  • Jennifer von Stein

  • Vera Fortmeier

  • Christoph Pauschinger

  • Wolfgang Rottbauer

  • Mohammad Kassar

  • Bjoern Goebel

  • Paolo Denti

  • Paul Achouh

  • Tienush Rassaf

  • Manuel Barreiro-Perez

  • Peter Boekstegers

  • Andreas Rück

  • Monika Zdanyte

  • Marianna Adamo

  • Flavien Vincent

  • Philipp Schlegel

  • Sebastian Rosch

  • Mirjam G. Wild

  • Christian Besler

  • Stefan Toggweiler

  • Stephanie Brunner

  • Julia Grapsa

  • Tiffany Patterson

  • Holger Thiele

  • Tobias Kister

  • Giuseppe Tarantini

  • Giulia Masiero

  • Marco De Carlo

  • Cristina Giannini

  • Fabian Voss

  • Amin Polzin

  • Antonio Popolo Rubbio

  • Francesco Bedogni

  • Thorald Stolte

  • Thomas Nestelberger

  • Tomás Benito-González

  • Enrique Sánchez-Muñóz

  • Martijn Vrijkorte

  • Martin Swaans

  • Mathias H. Konstandin

  • Eric Van Belle

  • Marco Metra

  • Tobias Geisler

  • Rodrigo Estévez-Loureiro

  • Amir Abbas Mahabadi

  • Nicole Karam

  • Francesco Maisano

  • Philipp Lauten

  • Mirjam Kessler

  • Daniel Kalbacher

  • Volker Rudolph

  • Christos Iliadis

  • Philipp Lurz

  • Fabien Praz

  • Lukas Stolz

  • Jörg Hausleiter

  • May 18, 2026

  • 0 min

Share

Clinical Scorecard: Effects of Prior Cardiac Surgery on Outcomes Following Transcatheter Edge-to-Edge Repair of the Tricuspid Valve: Findings from EuroTR

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients with symptomatic severe TR, particularly those with prior cardiac surgery (PCS), focusing on their unique challenges.
Care Setting

Key Highlights

  • highlight_3

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • E
      • v
      • a
      • l
      • u
      • a
      • t
      • e
      • p
      • r
      • o
      • c
      • e
      • d
      • u
      • r
      • a
      • l
      • o
      • u
      • t
      • c
      • o
      • m
      • e
      • s
      • i
      • n
      • c
      • l
      • u
      • d
      • i
      • n
      • g
      • r
      • e
      • s
      • i
      • d
      • u
      • a
      • l
      • T
      • R
      • s
      • e
      • v
      • e
      • r
      • i
      • t
      • y
      • a
      • n
      • d
      • f
      • u
      • n
      • c
      • t
      • i
      • o
      • n
      • a
      • l
      • c
      • l
      • a
      • s
      • s
      • a
      • t
      • f
      • o
      • l
      • l
      • o
      • w
      • -
      • u
      • p
      • ,
      • i
      • d
      • e
      • a
      • l
      • l
      • y
      • a
      • t
      • 1
      • m
      • o
      • n
      • t
      • h
      • ,
      • 6
      • m
      • o
      • n
      • t
      • h
      • s
      • ,
      • a
      • n
      • d
      • 1
      • y
      • e
      • a
      • r
      • .

      Risks

        Patient & Prescribing Data

        T-TEER shows therapeutic benefit but may have lower procedural success in patients with PCS, necessitating careful patient selection.

        Clinical Best Practices

        • best_practice_2

        Related Resources & Content

        Original Source(s)

        Related Content